Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy
Aside from antibodies, peptides show great potential as immune checkpoint inhibitors (ICIs) due to several advantages, such as better tumor penetration and lower cost. Lymphocyte-activation gene 3 (LAG-3) is an immune checkpoint which can induce T cell dysfunction through interaction with its solubl...
Збережено в:
| Автори: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2024-03-01
|
| Серія: | Acta Pharmaceutica Sinica B |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S221138352300480X |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
